MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Surmodics ROCE Ratio 2011-2026 | SRDX
Annual ROCE Ratio Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.75 | 4.29 | -20.39 | 4.78 | -0.95 | 5.15 | -0.18 | 5.5 | 17.54 | 20.31 | 18.42 | 20.11 | 16.99 | 5.45 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.31 | -20.39 | 6.59 |
Quarterly ROCE Ratio Surmodics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.11 | -14.95 | -10.78 | -4.28 | 14.77 | 38.36 | 31.41 | 5.89 | 0.18 | -24.58 | -21.84 | -11.9 | -13.6 | -9.58 | 1.04 | 5.32 | 3.79 | 6.36 | -0.51 | -0.79 | 3.89 | 3.84 | 3.56 | 4.4 | -1.01 | -7.34 | -6.49 | -7.69 | -5.07 | 1.99 | 0.79 | 4.41 | 7.86 | 12.47 | 16.1 | 17.19 | 18.01 | 18.21 | 19.44 | 21.47 | 22.33 | 21.36 | 22.17 | 20.87 | 21.31 | 20.43 | 19.94 | 20.02 | 19.94 | 19.89 | 20.48 | 18.95 | 15.16 | 13.75 | 10.85 | 2.08 | 3.05 | 2.31 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 38.36 | -24.58 | 6.9 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
29.32 | $ 8.93 | 0.68 % | $ 595 M | USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 13.59 | -0.44 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
1.9 | $ 25.69 | -0.54 % | $ 714 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
33.2 | $ 67.77 | 2.16 % | $ 26.4 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 153.44 | 1.05 % | $ 7.61 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 17.48 | 0.92 % | $ 931 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 88.41 | 1.41 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | $ 103.97 | 0.11 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.56 | 4.08 % | $ 470 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 16.52 | -4.45 % | $ 2.14 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 98.91 | 1.33 % | $ 8.16 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.94 | 3.52 % | $ 95.4 K | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 168.49 | 2.24 % | $ 29 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 194.82 | 1.79 % | $ 139 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 121.67 | 2.0 % | $ 19.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 198.5 | -0.23 % | $ 22 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
25.0 | $ 113.4 | 1.4 % | $ 34.5 B | USA |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.12 | 0.45 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 9.04 | 7.36 % | $ 256 M | Israel |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.28 | 0.42 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.22 | 1.15 % | $ 2 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 79.85 | 1.71 % | $ 5.39 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.41 | 3.68 % | $ 423 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 455.2 | 0.34 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 211.79 | 1.05 % | $ 25 B |  Schweiz |
 |
Celcuity
CELC
|
-97.97 | $ 114.48 | -0.37 % | $ 4.52 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.63 | 1.32 % | $ 395 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-76.66 | $ 198.58 | 0.45 % | $ 19.5 B | USA |
 |
OPKO Health
OPK
|
-7.58 | $ 1.2 | 0.42 % | $ 833 M | USA |